Actively Recruiting
FungiScope - A Global Emerging Fungal Infection Registry
Led by University of Cologne · Updated on 2023-12-05
1000
Participants Needed
1
Research Sites
1239 weeks
Total Duration
On this page
Sponsors
U
University of Cologne
Lead Sponsor
P
Pfizer
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
CONDITIONS
Official Title
FungiScope - A Global Emerging Fungal Infection Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cultural, histopathological, antigen or DNA evidence of invasive fungal infection
You will not qualify if you...
- Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
- Endemic fungal infection such as coccidioidomycosis or histoplasmosis
- Colonisation or other non-invasive infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany, 50937
Actively Recruiting
Research Team
O
Oliver A Cornely, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here